Biocon Limited (BIOCON) Stock Statistics & Valuation Metrics

Biocon Limited has a market cap or net worth of ₹701.09B. The enterprise value is ₹714.07B.

Biocon Limited has 1,620,907,700 shares outstanding. The number of shares has decreased by -2.65% in one year.

Biocon Limited’s return on equity (ROE) is 0.01 and return on invested capital (ROIC) is 2.30%.

The current PE Ratio of Biocon Limited is 128.0. Biocon Limited’s PEG ratio is -1.92.

In the last 12 months, Biocon Limited had revenue of 169.27B and earned 3.86B in profits. Earnings per share was 2.82.

In the last 12 months, operating cash flow was 8.03B and capital expenditures -8.61B, giving a free cash flow of -575.00M billion.

Biocon Limited pays an annual dividend of ₹0.5, resulting in a dividend yield of 0.12%

Biocon Limited upcoming earnings date is Aug 6, 2026, TBA (Confirmed).

Biocon Limited as a current ratio of 1.22, with Debt / Equity ratio of 45.35%

In the past 12 months, Biocon Limited has paid 791.00M in taxes.

Biocon Limited EV to EBITDA ratio is 17.82, with an EV/FCF ratio of -118.15.

Biocon Limited has ₹64.69B in cash and marketable securities with ₹165.35B in debt, giving a net cash position of -₹100.66B billion.

Gross margin is 50.04%, with operating margin of 8.85%, and net profit margin of 2.28%.

The average price target for Biocon Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―